Drug Information

General Information
Drug ID
DR00020
Drug Name
L-tyrosine
Synonyms
(-)-alpha-Amino-p-hydroxyhydrocinnamic acid; (2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid; (S)-2-Amino-3-(4-hydroxyphenyl)propionic acid; (S)-2-Amino-3-(p-hydroxyphenyl)propionic acid; (S)-3-(p-Hydroxyphenyl)alanine; (S)-Tyrosine; (S)-alpha-Amino-4-hydroxybenzenepropanoic acid; 2-Amino-3-(p-hydroxyphenyl)propionic acid; 3-(4-Hydroxyphenyl)-L-alanine; 3-(p-Hydroxyphenyl)alanine; 4-Hydroxy-L-phenylalanine; 4ts1; Alpha-Amino-beta-(4-hydroxyphenyl)propionic acid; Beta-(p-Hydroxyphenyl)alanine; DD69927C-C6A8-4BC6-8E9A-0AB423B176E7; DTY; Free-Form L-Tyrosine; H-Tyr-OH; L-(-)-Tyrosine; L-2-Amino-3-p-hydroxyphenylpropanoic acid; L-Tyrosin; L-Tyrosine (9CI); L-Tyrosine (JAN); L-Tyrosine hydrochloride; L-Tyrosine, homopolymer; L-Tyrosine, monomer; L-p-Tyrosine; Melanin synthesized from Tyr substrate catalyzed by tyrosinase for 6 hrs; Melanin synthesized from Tyr substrate catalyzed by tyrosinase for 6 hrs, oxidized with hydrogen peroxide; Melanin synthesized from Tyr substrate catalyzed by tyrosinase for 6 hrs, oxidized with hydrogen peroxide, <3 kd fraction; Melanin synthesized from Tyr substrate catalyzed by tyrosinase, brominated with N-bromosuccinimide; Melanin synthesized from Tyr substrate catalyzed by tyrosinase, sulfonated using sulfur trioxide/DMF complex for 1.5-7 hours; P-Tyrosine; Rxosine; TYR NH3+ COOH; Tirosina; Tirosina [Spanish]; Tyr; Tyrosine; Tyrosine (USP/INN); Tyrosine (VAN); Tyrosine Power; Tyrosine [USAN:INN]; Tyrosine, L-(8CI); Tyrosinum; Tyrosinum [Latin]
Drug Type
Small molecular drug
Indication Dietary shortage [ICD11: 5B7Z] Approved [1]
Therapeutic Class
Dietary supplement
Structure
3D MOL 2D MOL
Formula
C9H11NO3
Canonical SMILES
C1=CC(=CC=C1CC(C(=O)O)N)O
InChI
InChI=1S/C9H11NO3/c10-8(9(12)13)5-6-1-3-7(11)4-2-6/h1-4,8,11H,5,10H2,(H,12,13)/t8-/m0/s1
InChIKey
OUYCCCASQSFEME-QMMMGPOBSA-N
CAS Number
CAS 60-18-4
Pharmaceutical Properties Molecular Weight 181.19 Topological Polar Surface Area 83.6
Heavy Atom Count 13 Rotatable Bond Count 3
Hydrogen Bond Donor Count 3 Hydrogen Bond Acceptor Count 4
XLogP
-2.3
PubChem CID
6057
PubChem SID
10529154 , 11528398 , 14710671 , 15147336 , 15195185 , 24697644 , 24697646 , 24889931 , 24900164 , 24900206 , 24900543 , 24901863 , 25622129 , 26702499 , 26711663 , 26711664 , 26711665 , 26718889 , 26719042 , 29215265 , 29215266 , 29225067 , 3134840 , 3382 , 46394031 , 46394400 , 46504669 , 46507885 , 48416689 , 585619 , 585656 , 608132 , 7847090 , 7887220 , 7890924 , 8026808 , 8028352 , 8028353 , 8144790 , 8153780 , 817482 , 817486 , 817487 , 817488 , 817489 , 823160 , 828554 , 832231 , 841729 , 854649
ChEBI ID
ChEBI:17895
TTD Drug ID
D01CRB
DT(s) Transporting This Drug LAT2 Transporter Info L-type amino acid transporter 2 Substrate [2]
References
1 L-tyrosine was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 The Transporter Classification Database (TCDB): recent advances. Nucleic Acids Res. 2016 Jan 4;44(D1):D372-9. (ID: 2.A.3.8.20)

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.